Theranostic Nano-objects: Basic Principles and Initial Applications
治疗诊断纳米物体:基本原理和初步应用
基本信息
- 批准号:8411867
- 负责人:
- 金额:$ 119.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-27 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAntibodiesBasic ScienceBehaviorBehavior ControlBiological MarkersBoxingCancer PatientCell surfaceCellsComplexContrast MediaCuesDNADevelopmentDevicesDiabetes MellitusDiagnosticDiagnostic ImagingDropsEngineeringEnzymesEventFluorescenceFoundationsGenerationsGlucoseGoalsImageInsulinIntensive CareLabelLaboratoriesLeadLymphocyteLymphocyte SubsetMagnetic Resonance ImagingMapsMedicalMethodsMolecularMolecular MachinesMovementNanotechnologyOutcomePatientsProdrugsProtocols documentationShockSignal TransductionSolutionsStructure of beta Cell of isletSurfaceTechnologyTherapeuticToxinVasopressinsaptamerbasecell typeeggglucose oxidasein vivomolecular scalenanonanodiagnosticoperationpreventresponsesensortool
项目摘要
DESCRIPTION (provided by applicant): Our goal is to establish basic science foundations and engineering principles for the broad applications of theranostic (therapeutic+diagnostic) nano-objects, defined as compact autonomous molecular devices capable of analyzing multiple biomarkers before signaling that there are pathological events or before taking corrective actions. Our effort will center on methods to control behavior of dynamic "neggs" (nano-eggs), made of deoxyribonucleic acids, and comprising sensors, imaging and/or therapeutic moieties, and molecular computing functions. Neggs can open (be unlocked) or close (be locked) on cue, and this cue can be integrated information on the presence or absence of one or more biomarkers. In order to showcase the transformative potential of theranostic nano-objects, we will map increasingly complex engineered behaviors of neggs to proof-of-concepts for therapeutic applications for which no other existing technologies are satisfactory. For example, we will: (i) open a negg if an analyte raises above (e.g., glucose) or drops below (e.g., vasopressin) its "normal" concentration; (ii) mark for elimination/imaging narrow subpopulations of cells based on multiple surface markers, while protecting cells that differ in a single marker (e.g., on lymphocytes); and (iii) demonstrate amplification of MRI contrast agents on a targeted cell type (exemplified on b-cells). 1
PUBLIC HEALTH RELEVANCE: Theranostic (therapeutic+diagnostic) nano-objects are autonomous nanoscopic devices capable of analyzing in vivo multiple biomarkers before signaling the presence of pathological events (imaging/diagnostics) or before taking corrective actions when needed (therapeutics). They can autonomously control levels of glucose in diabetes, prevent irreversible shock in an intensive care patient, or selectively eliminate very narrow subpopulations of cells in a cancer patient.
描述(由申请人提供):我们的目标是为治疗诊断(治疗+诊断)纳米物体的广泛应用建立基本的科学基础和工程原理,纳米物体被定义为紧凑的自主分子设备,能够在发出病理事件信号或采取纠正措施之前分析多种生物标志物。我们的努力将集中在控制动态“neggs”(纳米蛋)的行为的方法上,这些纳米蛋由脱氧核糖核酸制成,包括传感器、成像和/或治疗部分以及分子计算功能。核可以根据提示打开(解锁)或关闭(锁定),并且该提示可以是关于一种或多种生物标志物的存在或不存在的整合信息。为了展示治疗诊断纳米物体的变革潜力,我们将把越来越复杂的neggs工程行为映射到治疗应用的概念验证中,对于这些应用,没有其他现有技术是令人满意的。例如,我们将:(i)如果分析物升高到高于(例如,葡萄糖)或低于(例如,加压素)其“正常”浓度;(ii)基于多个表面标记物标记用于消除/成像细胞的窄亚群,同时保护在单一标记物上不同的细胞(例如,在淋巴细胞上);和(iii)证明MRI造影剂在靶细胞类型上的扩增(以b细胞为例)。1
公共卫生相关性:治疗诊断(治疗+诊断)纳米物体是自主的纳米设备,能够在发出病理事件(成像/诊断)的存在信号之前或在需要时采取纠正措施(治疗)之前分析体内多种生物标志物。它们可以自主控制糖尿病患者的葡萄糖水平,防止重症监护患者的不可逆休克,或选择性地消除癌症患者中非常狭窄的细胞亚群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Milan N Stojanovic其他文献
Milan N Stojanovic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Milan N Stojanovic', 18)}}的其他基金
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10429939 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10388660 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10647742 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10795432 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10190976 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10033063 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Automated Microfluidic Selection of Aptamers against Carbohydrates
针对碳水化合物的适配体的自动微流体选择
- 批准号:
8985077 - 财政年份:2015
- 资助金额:
$ 119.07万 - 项目类别:
Isolation of narrow subpopulations of cells using molecular computing cascades
使用分子计算级联分离狭窄的细胞亚群
- 批准号:
8302751 - 财政年份:2012
- 资助金额:
$ 119.07万 - 项目类别:
Theranostic Nano-objects: Basic Principles and Initial Applications
治疗诊断纳米物体:基本原理和初步应用
- 批准号:
8730687 - 财政年份:2012
- 资助金额:
$ 119.07万 - 项目类别:
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 119.07万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 119.07万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 119.07万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 119.07万 - 项目类别: